Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Translational Oncology|December 19, 2016
MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motilityDaniel Luxen, Gerrit H Gielen, Anke Waha, et al.
International Journal of Cancer|March 22, 2007
Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomasArend Koch, Aksana Hrychyk, Wolfgang Hartmann, et al.
The American Journal of Pathology|June 13, 2012
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomasTim Müller, Marco Gessi, Anke Waha, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.
Oncology|September 7, 2013
FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survivalChristina Schaub, Susanne Greschus, Mirko Seifert, et al.
Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.
Pharmaceutics|August 29, 2024
Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug ScreeningSaif-Eldin Abedellatif, Racha Hosni, Andreas Waha, et al.
British Journal of Cancer|August 16, 2019
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survivalMohummad Aminur Rahman, Andrea Gras Navarro, Jorunn Brekke, et al.
Brain Pathology (Zurich, Switzerland)|September 19, 2014
Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular EntityGerrit H Gielen, Marco Gessi, Francesca R Buttarelli, et al.
Pageof 8